Amphastar Pharmaceuticals, Inc. — Director's Dealing 2016

Dec 17, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2016-12-15

Reporting Person: Gerst Diane G. (EVP, QA & Regulatory Affairs)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-15	Common Stock	S	2940	$20.5057	Disposed	26195	Direct

Footnotes

F1: Includes 150 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.45 to $20.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.